Delivery Order SPE2DR25D3101-SPE2DR26F5S33
- Not listed
- The Defense Logistics Agency awarded a $3,198.34 delivery order to AmerisourceBergen Drug Corp for Droperidol 5 mg/2 ml vials on July 30, 2025, with completion targeted for July 31, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order for pharmaceutical supplies performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Droperidol is an antipsychotic medication commonly utilized in military and federal healthcare settings for...
- The Defense Logistics Agency awarded a delivery order valued at $5,880.56 to AmerisourceBergen Drug Corp for the supply of Droperidol 5 mg/2 ml vials on November 6, 2025, with completion scheduled for November 7, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4559457145 - Droperidol 5 mg/2 ml vial, 2 ml, with a ceiling value of $1,146.00 and a completion date of December 28, 2022. This contract is not designated as a set-aside and is a firm fixed-price arrangement. AmerisourceBergen Drug Corp is a for-profit organization registered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for pharmaceutical products valued at $1,184.60. The award is for XDEMVY 0.25% Drop 10ML and is structured as a firm fixed price delivery order with an ultimate completion date of November 24, 2025. This non-competitive award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML on December 2, 2025, with an ultimate completion date of December 23, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical supply will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML pharmaceutical products. This firm fixed price, competitively awarded delivery order is scheduled for completion by December 8, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML pharmaceutical products. This firm fixed-price, competitively awarded contract was issued on December 1, 2025, with an ultimate completion date of December 22, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,223.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product, with an ultimate completion date of October 17, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for XDEMVY 0.25% DROP 10ML, a pharmaceutical product. This firm fixed-price delivery order, issued on October 30, 2025, is scheduled for completion by November 21, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of XDEMVY 0.25% Drop 10ML, a pharmaceutical product. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,223.59 and is scheduled for completion by August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under a larger...
- SPE2DR25D3101Indefinite Delivery Contract
- SPE2DR25D3101-SPE2DR26F5S33Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Droperidol 5 mg/2 mL vials with a ceiling value of $10,318.19. This is a firm fixed-price delivery order with no set-aside designation, placing performance in Conshohocken, Pennsylvania, and scheduled for completion by December 10, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated substantial capability in federal medical procurement through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company supplies a comprehensive range of pharmaceuticals and medical commodities to support military and veteran healthcare systems, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Droperidol, an antipsychotic medication commonly used in military medical settings, reflects the company's continued role as a critical vendor for federal medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 12/8/25 |